Lysosome-mediated chemoresistance in acute myeloid leukemia

Despite the outstanding advances in understanding the biology underlying the pathophysiology of acute myeloid leukemia (AML) and the promising preclinical data published lastly, AML treatment still relies on a classic chemotherapy regimen largely unchanged for the past five decades. Recently, new dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuesta-Casanovas, Laia, Delgado-Martínez, Jennifer, Cornet-Masana, Josep M., Carbó, José M., Clément-Demange, Lise, Risueño, Ruth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992599/
https://www.ncbi.nlm.nih.gov/pubmed/35582535
http://dx.doi.org/10.20517/cdr.2021.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992599/
https://www.ncbi.nlm.nih.gov/pubmed/35582535
http://dx.doi.org/10.20517/cdr.2021.122

Ejemplares similares